Kolinpharma® obtains 3 patents in European Union with validation in 12 new countries beyond Italy. -28/5/2020

Kolinpharma® expands on the European market and obtains the patent for 3 products with validation in 12 new countries.

By obtaining 3 patents for Xinepa® (formulation patent and technological process patent) and Almetax® (formulation patent), as well as validation for the official entry into the markets of 12 new European countries beyond Italy, the foundations were laid for expansion in Europe. We continue our growth path. This is a great milestone that sees the company move forward in a reference market characterized by large volumes and constant growth.